2024-07-25 13:03:51 ET
Summary
- Agilent Technologies shares looked appealing in 2023, trading at a reasonable 21 times forward earnings multiple.
- The company saw a tough year in 2024, with soft operating performance and lowered guidance, despite a strategic bolt-on deal with BIOVECTRA.
- Shares have recovered from lows of $100 to highs of $155, but uncertainty remains as the company struggles with sluggish performance.
- With a softer 2024 performance seen (again) the company has resorted to a strategic bolt-on deal with BIOVECTRA.
In May of last year, I believed that shares of Agilent Technologies, Inc. ( A ) were starting to look appealing. Shares have traditionally traded at a premium, amidst a solid positioning and continued M&A efforts. Following a sluggish share price, shares traded at a very reasonable 21 times forward earnings multiple last year, which looked quite compelling....
Read the full article on Seeking Alpha
For further details see:
Agilent: Making A Move To Ignite Some Growth